Literature DB >> 2958399

Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis.

K D Lindor1, R H Wiesner, N F LaRusso, H A Homburger.   

Abstract

Primary sclerosing cholangitis is a chronic, cholestatic liver disease in which immune mechanisms are thought to play a role in the pathogenesis. We have determined the frequencies and functional phenotypes of autoreactive T-lymphocytes in peripheral blood specimens from patients with primary sclerosing cholangitis and healthy adults as an indicator of autoreactivity in primary sclerosing cholangitis. We found a significant increase in the percentage of autoreactive suppressor/cytotoxic T-lymphocytes that become activated in the T-, non-T-autologous mixed lymphocyte reaction in primary sclerosing cholangitis patients (p less than 0.002). Blastogenesis in autologous mixed lymphocyte reaction cultures from primary sclerosing cholangitis patients was significantly decreased (p less than 0.02), and the magnitude of the decrease correlated directly with the percentage of activated suppressor/cytotoxic T-lymphocytes (r = 0.56, p less than 0.01). The percentage of autoreactive, suppressor T-lymphocytes was increased in autologous mixed lymphocyte reaction cultures from primary sclerosing cholangitis patients (p less than 0.0001); and suppression of mitogen-induced blastogenesis by autologous concanavalin A-treated mononuclear cells was significantly enhanced. These results, which were unrelated to the histologic stage of liver disease and the presence or absence of active colitis, document the presence of an expanded population of T-lymphocytes in the peripheral blood of patients with primary sclerosing cholangitis that became activated on exposure to autologous major histocompatibility antigens in the autologous mixed lymphocyte reaction. We hypothesize that these autoreactive cells may be a marker or may participate as effector cells in cell-mediated autoimmunity in primary sclerosing cholangitis.

Entities:  

Mesh:

Year:  1987        PMID: 2958399     DOI: 10.1002/hep.1840070515

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Suppressor T-cell deficiency in primary sclerosing cholangitis. Case and family study.

Authors:  A E Kilby; E L Krawitt; R J Albertini; B F Chastenay; A John
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

3.  Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis.

Authors:  X Bo; U Broome; M Remberger; S Sumitran-Holgersson
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

4.  The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation.

Authors:  A Shaked; J O Colonna; L Goldstein; R W Busuttil
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

Review 5.  Aetiology and pathophysiology of chronic liver disorders.

Authors:  J Schölmerich; A Holstege
Journal:  Drugs       Date:  1990       Impact factor: 9.546

6.  A longitudinal study of histologic and immunohistologic changes in an experimental model of sclerosing cholangitis.

Authors:  P Bedossa; S Houry; J Bacci; E Martin; G Lemaigre; M Huguier
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.

Authors:  S Bloom; K Fleming; R Chapman
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

8.  Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis.

Authors:  J S Gavaler; B Delemos; S H Belle; A E Heyl; R E Tarter; T E Starzl; C Gavaler; D H van Thiel
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

9.  Alopecia areata, primary sclerosing cholangitis, and ulcerative colitis: autoimmunity and apoptosis as common links?

Authors:  Panagiotis Katsinelos; Jannis Kountouras; George Paroutoglou; Christos Zavos
Journal:  Dig Dis Sci       Date:  2007-03-20       Impact factor: 3.487

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.